Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period from November 1, 2013, to April 30, 2014, with the report dated May 14, 2014. The document serves as a "Block Listing Six Monthly Return" detailing the status of various employee share option and savings-related share schemes. It is not a financial results report.
Key Financial Metrics
The filing text does not provide data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document exclusively reports on the number of securities available under specific equity compensation plans.
Material Changes in Equity Schemes
The filing details the movement of unallotted securities across ten distinct schemes. Key changes during the six-month period include:
- GlaxoSmithKline Share Option Plan - Ordinary Shares: 2,403,841 securities were issued/allotted, reducing the balance from 9,758,028 to 7,354,187.
- GlaxoSmithKline Share Option Plan - ADS: 7,203,296 securities were issued/allotted, reducing the balance from 8,875,532 to 1,672,236.
- GlaxoSmithKline plc Sharesave plan 2012: The scheme was increased by 50,000 securities. Additionally, 29,811 securities were issued/allotted, resulting in an ending balance of 29,873.
- Other Schemes: No securities were issued or allotted, and no increases were applied for in the Glaxo Wellcome UK, Glaxo Wellcome International, Glaxo Wellcome 1999, SmithKline Beecham 1989 (Approved/Unapproved), and GlaxoSmithKline Savings Related Share Option Scheme.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly a regulatory update on share scheme inventory.
Investor Verification Points
- Verify the total number of shares issued under the ADS and Ordinary Share Option Plans to assess potential dilution impact.
- Confirm the remaining balance of the "GlaxoSmithKline Share Option Plan - ADS" (1,672,236) to evaluate future option grant capacity.
- Review the increase of 50,000 shares in the "Sharesave plan 2012" to understand changes in employee savings incentives.
- Note that no new shares were allocated to legacy schemes (e.g., SmithKline Beecham 1989 plans), indicating these may be nearing closure or are inactive.